Abstract:STUDY QUESTION Does maternal periconceptional no folic acid supplementation have an increased risk of neural tube defects (NTDs) associated with previous spontaneous abortion or first-trimester fever? SUMMARY ANSWER Maternal periconceptional no folic acid supplementation can increase the risk of NTDs associated with previous spontaneous abortion or first-trimester fever, independent of known confounding factors. WHAT IS KNOWN ALREADY Maternal periconceptional folic acid deficiency can increase the risk of NTDs. However, whether an interaction between periconceptional no folic acid supplementation and history of spontaneous abortion or first-trimester fever may have an increased risk of NTDs remains unknown. STUDY DESIGN, SIZE, DURATION A population-based case-control study was performed including 104 nuclear families with offspring with NTDs and 100 control families with normal offspring between 1993 and 2002. PARTICIPANTS/MATERIALS, SETTING, METHODS We investigated the potential interaction between periconceptional no folic acid use and a maternal history of spontaneous abortion or first-trimester fever in the risk for NTDs. Information on exposure factors was obtained at the onset of pregnancy, and pregnancy outcomes were collected during the first week after delivery or at the time of termination of the pregnancy. A multivariate logistic regression analysis was performed. MAIN RESULTS AND THE ROLE OF CHANCE The interaction between periconceptional no folic acid use and a maternal history of spontaneous abortion markedly increased the risk of NTDs (adjusted odds ratio (aOR) 18.68, 95% CI, 4.43-78.76) after adjusting for potential confounding factors. The interaction coefficient was found to be 2.08, higher than 1, indicating that there is a significant interaction between two factors. Mothers who did not take periconceptional folic acid and had first-trimester fever had an increased risk of NTDs (aOR 21.81, 95% CI, 8.81-80.73). However, the interaction coefficient was found to be 0.62, less than 1, indicating that there is no significant interaction between two factors. LIMITATIONS, REASONS FOR CAUTION A potential limitation was that the interval between the previous spontaneous abortion and the beginning of the subsequent pregnancy could not be estimated accurately, but was at least 1 year or more. WIDER IMPLICATIONS OF THE FINDINGS We emphasize that a previous spontaneous abortion may represent a first occurrence of NTDs rather than be the cause of NTDs. Our findings indicate that mothers with a history of spontaneous abortion are ideal candidates for periconceptional folic acid supplementation. STUDY FUNDING/COMPETING INTEREST(S) This work was supported by National Natural Science Foundation of China (41871360) and Danone Nutrition Center for Dietary Nutrition Research and Education Foundation (DIC2015-05). There are no competing interests to declare.

Interaction Between the SLC19A1 Gene and Maternal First Trimester Fever on Offspring Neural Tube Defects

Periconceptional Factors Affect the Risk of Neural Tube Defects in Offspring: a Hospital-Based Case-Control Study in China.

Maternal body mass index and the association between folic acid supplements and neural tube defects.

Maternal Flu or Fever, Medications Use in the First Trimester and the Risk for Neural Tube Defects: a Hospital-Based Case–control Study in China

Association of Reduced Folate Carrier Gene Polymorphism and Maternal Folic Acid Use with Neural Tube Defects

Nausea and Vomiting in Early Pregnancy and the Risk of Neural Tube Defects: a Case-Control Study.

Reduced folate carrier gene is a risk factor for neural tube defects in a Chinese population.

Interaction Between Maternal Periconceptional Supplementation of Folic Acid and Reduced Folate Carrier Gene Polymorphism of Neural Tube Defects

[Epidemiological Study on Reduced Folate Carrier Gene(rfc1 A80G) Polymorphism and Other Risk Factors of Neural Tube Defects].

[A Parental Case Control Study on the Association Between Reduced Folate Carrier Gene Polymorphism and Neural Tube Defects].

MTHFD1 polymorphism as maternal risk for neural tube defects: a meta-analysis

Association Between Maternal Single Nucleotide Polymorphisms in Genes Regulating Glucose Metabolism and Risk for Neural Tube Defects in Offspring.

High Ratios Of C20:4n-6/C20:5n-3 And Thromboxane B-2/6-Keto-Prostaglandin F-1 Alpha In Placenta Are Potential Risk Contributors For Neural Tube Defects: A Case-Control Study In Shanxi Province, China

High Ratios of C20:4n-6/C20:5n-3 and Thromboxane B2 /6-Keto-prostaglandin F1α in Placenta Are Potential Risk Contributors for Neural Tube Defects: A Case-Control Study in Shanxi Province, China.

Effect of Periconceptional Folic Acid Supplementation on the Risk of Neural Tube Defects Associated with a Previous Spontaneous Abortion or Maternal First-Trimester Fever

Maternal Flu Or Fever, Medication Use, And Neural Tube Defects: A Population-Based Case-Control Study In Northern China

Erratum To: Variants in Maternal COMT and MTHFR Genes and Risk of Neural Tube Defects in Offspring

Association Of The Maternal Mthfr C677t Polymorphism With Susceptibility To Neural Tube Defects In Offsprings: Evidence From 25 Case-Control Studies

Family-Based Association Test for Reduced Folate Carrier Gene Polymorphism of Parent and Offspring with Neural Tube Defects

Levels of Folate Receptor Autoantibodies in Maternal and Cord Blood and Risk of Neural Tube Defects in a Chinese Population

Maternal Genetic Polymorphisms of Phase Ii Metabolic Enzymes and the Risk of Fetal Neural Tube Defects